Net Cash Provided by (Used in) Financing Activities of BioAtla, Inc. from 31 Dec 2019 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
BioAtla, Inc. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2019 to 31 Mar 2025.
  • BioAtla, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $395,000, a 2938% decline year-over-year.
  • BioAtla, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $9,511,000, a 12252% increase from 2023.
  • BioAtla, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $77,000, a 100% decline from 2022.
  • BioAtla, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $61,213,000, a 12% decline from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

BioAtla, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $395,000 -$382,000 -2938% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q1 2024 $13,000 +$103,000 +89% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q1 2023 $116,000 +$289,000 +71% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q1 2022 $405,000 +$1,506,000 +79% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q1 2021 $1,911,000 -$2,411,000 -482% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q1 2020 $500,000 01 Jan 2020 31 Mar 2020 10-Q 12 May 2021 2021 Q1

BioAtla, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $9,511,000 +$9,434,000 +12252% 01 Jan 2024 31 Dec 2024 10-K 28 Mar 2025 2024 FY
2023 $77,000 -$61,136,000 -100% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2025 2024 FY
2022 $61,213,000 -$8,299,000 -12% 01 Jan 2022 31 Dec 2022 10-K 26 Mar 2024 2023 FY
2021 $69,512,000 -$202,313,000 -74% 01 Jan 2021 31 Dec 2021 10-K 23 Mar 2023 2022 FY
2020 $271,825,000 +$267,830,000 +6704% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2022 2021 FY
2019 $3,995,000 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.